$HIPH- New press release out this am! American Premium

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
492
$HIPH- New press release out this am!

American Premium Water Corp. Ramps Production and Reduces CostsPress Release | 04/12/2018

PLAYA VISTA, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- American Premium Water Corporation (OTC Pink:HIPH) (the “Company”) announces that they have entered into a long-term supply agreement with a US-based hydrogen beverage supplier enabling the company to increase and streamline production while reducing cost.

This agreement gives the Company a manufacturing partner that has the capability to scale. The first order for LALPINA Hydrogen has already been placed and the product will be available for sale across all channels in the next few weeks.

Ryan Fishoff, CEO American Premium Water Corporation, commented: “This supply agreement is a pinnacle step in establishing LALPINA as the market leader in hydrogen energy products. This agreement not only provides us with a stable supply, but it also allows us to manufacture LALPINA Hydrogen domestically, which will significantly reduce shipping costs. It will also significantly reduce lead times, which will allow us to better utilize capital and not have it tied up with in-transit inventory.”

Previously, HIPH was sourcing its LALPINA Hydrogen from Japan. The Company will still continue its relationship with this supplier as it eyes expansion into Asia, leveraging HIPH’s Gents subsidiary’s joint-venture in China as a platform for Asian expansion.

“In addition to no longer having to ship the product over the Pacific, our new supplier is producing LALPINA in metal cans, which will increase the shelf life of the product by 100%. (90 to 180 days). This will greatly expand the pool of retailers who can now carry our product, expanding our potential reach, maximizing our ability to capture market share and drive revenue growth. The supplier can also produce CBD infused hydrogen and other hydrogen infused products that we are excited about and will be announcing as they become available,” added Mr. Fishoff.

HIPH is still on schedule to release LALPINA Hydrogen CBD by the end of June or sooner. The Company has started initial R&D with its new supplier on developing a hydrogen CBD beverage formulated specifically for the pets. The pet market is currently estimated to be a $26 Billion industry according to the market research firm Packaged Facts.

“The pet food industry is huge. Being a pet owner myself, I know what pet owners will do (and spend) for their pets. I recently learned that Chrissy Teigen tried CBD to ease her bulldog’s pain, and I think hydrogen can be an effective CBD delivery system for pets as well. If my bulldog had the same issues, I would do and spend whatever I had to alleviate its pain. I look forward to working with our new supplier to develop this among products for many other applications. I also want to explore doing a THC/Cannabis beverage for the states where it is legal. These are all products that we can offer to establish LALPINA as the preeminent hydrogen infused brand,” Mr. Fishoff concluded.

American Premium Water Corp is the publicly holding trading company that owns LALPINA HYDROGEN, LALPINA HYDROGEN CBD & Gents.

Please follow us on our social media outlets listed below:

@americanpremium

@lalpinabrands

@GentsCo

#Gentsco

#lalpinahydrogen

For more information on American Premium Water Corporation / HIPH, go to http://www.lalpinahydrogen.com/investor-page.html

Gents

The New York-based Gents is a producer of luxury hats and other fine accessories and apparel. Their line is carried in over 200 retail outlets internationally, including Bloomingdale’s, Nordstrom, and Saks Fifth Avenue.

Visit www.gentsco.com to learn more. https://www.gentsco.com

@GentsCo

#GentsCo
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 87

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 68

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 43

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 730

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 323

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 226

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 73

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 228

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
aria-label="Continue reading: JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer"> Continue Reading